{"transactions":[{"id":672956,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ADSs","published_at":"2026-08-28T22:40:46.000Z","date":"2026-08-27","kind":"grant","planned":false,"acquired":true,"shares":34534,"price":5.15,"value":177850.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Ordinary Shares are represented by American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five (35) ordinary shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 27, 2026, the Issuer and the Reporting Person, entered into an exchange agreement, pursuant to which $177,849 of accrued interest outstanding (\"Outstanding Debt\") owed in connection with a note previously purchased by the Reporting Person was exchanged for 34,534 ADSs. The exchange agreement and the exchange of the Outstanding Debt for the ADSs was approved in advance by the Issuer's audit committee and board of directors."}],"balance_after":56243,"source":{"system":"sec-edgar","filing":"0001104659-26-103376","document":"tm2624320-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926103376/tm2624320-2_4seq1.xml","form_type":"4"}},{"id":916025,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-02-06T22:15:46.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":21709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four annual installments with 20% vesting on each of February 4, 2027, 2028 and 2029 and 40% vesting on February 4, 2030."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."}],"balance_after":21709,"derivative":{"exercise_price":7.37,"expiration_date":"2036-02-04","underlying":"ADS","underlying_shares":21709},"source":{"system":"sec-edgar","filing":"0001104659-26-011613","document":"tm265448-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926011613/tm265448-3_4seq1.xml","form_type":"4"}},{"id":1018436,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series K Warrants (Right to Buy)","published_at":"2025-10-15T21:15:20.000Z","date":"2025-10-14","kind":"purchase","planned":false,"acquired":true,"shares":15152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each ADS purchased together with a Series H Warrant, a Series I Warrant, a Series J Warrant and a Series K Warrant to purchase one ADS in the Issuer's private placement which closed on October 14, 2025, at a combined price of $8.49. The Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants are collectively referred to as the \"Warrants.\""},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each ADS purchased together with a Series H Warrant, a Series I Warrant, a Series J Warrant and a Series K Warrant to purchase one ADS in the Issuer's private placement which closed on October 14, 2025, at a combined price of $8.49. The Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants are collectively referred to as the \"Warrants.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Warrants were exercisable immediately upon issuance, subject to a beneficial ownership cap."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Series K Warrants will expire on the earlier of (i) five (5) years from the Closing Date or (ii) 30 days after the public announcement of the Company's sale of a Priority Review Voucher (PRV)."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Ordinary Shares are represented by American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five (35) ordinary shares of the Issuer."}],"balance_after":15152,"derivative":{"exercise_price":12.375,"exercise_date":"2025-10-14","underlying":"ADS","underlying_shares":15152},"source":{"system":"sec-edgar","filing":"0001104659-25-099782","document":"tm2528832-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925099782/tm2528832-1_4seq1.xml","form_type":"4"}},{"id":1018435,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series J Warrants (Right to Buy)","published_at":"2025-10-15T21:15:20.000Z","date":"2025-10-14","kind":"purchase","planned":false,"acquired":true,"shares":15152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each ADS purchased together with a Series H Warrant, a Series I Warrant, a Series J Warrant and a Series K Warrant to purchase one ADS in the Issuer's private placement which closed on October 14, 2025, at a combined price of $8.49. The Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants are collectively referred to as the \"Warrants.\""},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each ADS purchased together with a Series H Warrant, a Series I Warrant, a Series J Warrant and a Series K Warrant to purchase one ADS in the Issuer's private placement which closed on October 14, 2025, at a combined price of $8.49. The Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants are collectively referred to as the \"Warrants.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Warrants were exercisable immediately upon issuance, subject to a beneficial ownership cap."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series J Warrants will expire on the earlier of (i) five (5) years from the Closing Date or (ii) 30 days after the public announcement of the receipt of either accelerated or traditional approval by the FDA of QRX003 for the treatment of Netherton Syndrome."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Ordinary Shares are represented by American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five (35) ordinary shares of the Issuer."}],"balance_after":15152,"derivative":{"exercise_price":12.375,"exercise_date":"2025-10-14","underlying":"ADS","underlying_shares":15152},"source":{"system":"sec-edgar","filing":"0001104659-25-099782","document":"tm2528832-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925099782/tm2528832-1_4seq1.xml","form_type":"4"}},{"id":1018434,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series I Warrants (Right to Buy)","published_at":"2025-10-15T21:15:20.000Z","date":"2025-10-14","kind":"purchase","planned":false,"acquired":true,"shares":15152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each ADS purchased together with a Series H Warrant, a Series I Warrant, a Series J Warrant and a Series K Warrant to purchase one ADS in the Issuer's private placement which closed on October 14, 2025, at a combined price of $8.49. The Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants are collectively referred to as the \"Warrants.\""},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each ADS purchased together with a Series H Warrant, a Series I Warrant, a Series J Warrant and a Series K Warrant to purchase one ADS in the Issuer's private placement which closed on October 14, 2025, at a combined price of $8.49. The Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants are collectively referred to as the \"Warrants.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Warrants were exercisable immediately upon issuance, subject to a beneficial ownership cap."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series I Warrants will expire as follows: (i) 50% of the Series I Warrants will expire on the earlier of (A) five (5) years from the Closing Date or (B) 30 days after the Company's public announcement that the primary endpoint has been met in the monotherapy pivotal trial of QRX003 for the treatment of Netherton Syndrome, and (ii) 50% of the Series I Warrants will expire on the earlier of (A) five (5) years from the Closing Date or (B) 30 days after the Company's public announcement that the primary endpoint has been met in the adjuvant pivotal trial of QRX003 for the treatment of Netherton Syndrome."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Ordinary Shares are represented by American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five (35) ordinary shares of the Issuer."}],"balance_after":15152,"derivative":{"exercise_price":10.3125,"exercise_date":"2025-10-14","underlying":"ADS","underlying_shares":15152},"source":{"system":"sec-edgar","filing":"0001104659-25-099782","document":"tm2528832-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925099782/tm2528832-1_4seq1.xml","form_type":"4"}},{"id":1018433,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series H Warrants (Right to Buy)","published_at":"2025-10-15T21:15:20.000Z","date":"2025-10-14","kind":"purchase","planned":false,"acquired":true,"shares":15152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each ADS purchased together with a Series H Warrant, a Series I Warrant, a Series J Warrant and a Series K Warrant to purchase one ADS in the Issuer's private placement which closed on October 14, 2025, at a combined price of $8.49. The Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants are collectively referred to as the \"Warrants.\""},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each ADS purchased together with a Series H Warrant, a Series I Warrant, a Series J Warrant and a Series K Warrant to purchase one ADS in the Issuer's private placement which closed on October 14, 2025, at a combined price of $8.49. The Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants are collectively referred to as the \"Warrants.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Warrants were exercisable immediately upon issuance, subject to a beneficial ownership cap."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series H Warrants will expire on the earlier of (i) five (5) years from the Closing Date or (ii) 30 days after the Company's public announcement that the Company has received Type C meeting minutes from the FDA indicating openness to baseline-controlled pivotal studies for QRX003 for the treatment of Netherton Syndrome."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Ordinary Shares are represented by American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five (35) ordinary shares of the Issuer."}],"balance_after":15152,"derivative":{"exercise_price":9.075,"exercise_date":"2025-10-14","underlying":"ADS","underlying_shares":15152},"source":{"system":"sec-edgar","filing":"0001104659-25-099782","document":"tm2528832-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925099782/tm2528832-1_4seq1.xml","form_type":"4"}},{"id":1018432,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"ADSs","published_at":"2025-10-15T21:15:20.000Z","date":"2025-10-14","kind":"purchase","planned":false,"acquired":true,"shares":15152,"price":8.49,"value":128640.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Ordinary Shares are represented by American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five (35) ordinary shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Each ADS purchased together with a Series H Warrant, a Series I Warrant, a Series J Warrant and a Series K Warrant to purchase one ADS in the Issuer's private placement which closed on October 14, 2025, at a combined price of $8.49. The Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants are collectively referred to as the \"Warrants.\""}],"balance_after":15153,"source":{"system":"sec-edgar","filing":"0001104659-25-099782","document":"tm2528832-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925099782/tm2528832-1_4seq1.xml","form_type":"4"}},{"id":1056812,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-08-25T20:05:35.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":13682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"date","element":"transactionDate","label":"F2","text":"The option grant was approved by the Compensation Committee and the Board on May 29, 2025, subject to shareholder approval. The Company's shareholder's approved this option grant on August 21, 2025."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four annual installments with 20% vesting on each of May 29, 2026, 2027 and 2028 and 40% vesting on May 29, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."}],"balance_after":13682,"derivative":{"exercise_price":9.07,"expiration_date":"2035-05-28","underlying":"ADS","underlying_shares":13682},"source":{"system":"sec-edgar","filing":"0001104659-25-082511","document":"tm2524172-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925082511/tm2524172-1_4seq1.xml","form_type":"4"}},{"id":1127658,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-06-03T00:38:31.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":7760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four annual installments with 20% vesting on each of May 29, 2026, 2027 and 2028 and 40% vesting on May 29, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents thirty-five ordinary shares of the Issuer."}],"balance_after":7760,"derivative":{"exercise_price":9.07,"expiration_date":"2035-05-29","underlying":"ADS","underlying_shares":7760},"source":{"system":"sec-edgar","filing":"0001104659-25-055629","document":"tm2516320-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925055629/tm2516320-3_4seq1.xml","form_type":"4"}},{"id":1337198,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-12-10T21:45:20.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":50714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four annual installments with 20% vesting on each of December 9, 2025, 2026 and 2027 and 40% vesting on December 9, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."}],"balance_after":50714,"derivative":{"exercise_price":0.78,"expiration_date":"2034-12-09","underlying":"ADS","underlying_shares":50714},"source":{"system":"sec-edgar","filing":"0001104659-24-127230","document":"tm2430519-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924127230/tm2430519-1_4seq1.xml","form_type":"4"}},{"id":1484932,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-10T20:10:12.000Z","date":"2024-06-07","kind":"sale","planned":false,"acquired":false,"shares":297,"price":0.732,"value":217.404,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"). Each ADS represents one ordinary share of the Issuer."}],"balance_after":53,"source":{"system":"sec-edgar","filing":"0001104659-24-070017","document":"tm2416851-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924070017/tm2416851-1_4seq1.xml","form_type":"4"}},{"id":1753826,"issuer":{"id":7876,"kind":"organization","name":"Quoin Pharmaceuticals Ltd."},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2023-10-30T20:05:34.000Z","date":"2023-10-26","kind":"grant","planned":false,"acquired":true,"shares":7652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four annual installments with 20% vesting on each of October 26, 2024, 2025 and 2026 and 40% vesting on October 26, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares (\"ADSs\"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS."}],"balance_after":7652,"derivative":{"exercise_price":5.75,"exercise_date":"2024-10-26","expiration_date":"2033-10-26","underlying":"American Depositary Share","underlying_shares":7652},"source":{"system":"sec-edgar","filing":"0001104659-23-112558","document":"tm2329341-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465923112558/tm2329341-5_4seq1.xml","form_type":"4"}},{"id":2246014,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T21:28:38.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":17275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the Date of Grant and (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":106802,"source":{"system":"sec-edgar","filing":"0001628280-22-016225","document":"wf-form4_165429170294984.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022016225/wf-form4_165429170294984.xml","form_type":"4"}},{"id":2478291,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true}}],"security":"Stock Option","published_at":"2021-12-11T02:00:37.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 22,336 of the shares subject to the option vest and become exercisable as of 12:01 a.m. Eastern time on the date of the issuer's 2022 Annual Meeting of Stockholders and the remaining 44,664 shares vest and become exercisable in equal monthly installments over the following 24 months, subject to continued service through each vesting date."}],"balance_after":67000,"derivative":{"exercise_price":5.94,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001140361-21-041284","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036121041284/form4.xml","form_type":"4"}},{"id":2613686,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-05T21:11:17.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":25.39,"expiration_date":"2021-12-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001274225-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422521000004/edgardoc.xml","form_type":"4"}},{"id":2613685,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T21:11:17.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":30000,"price":34.75,"value":1042500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":89527,"source":{"system":"sec-edgar","filing":"0001274225-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422521000004/edgardoc.xml","form_type":"4"}},{"id":2613684,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T21:11:17.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":30000,"price":25.39,"value":761700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":119527,"source":{"system":"sec-edgar","filing":"0001274225-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422521000004/edgardoc.xml","form_type":"4"}},{"id":2681729,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T22:58:35.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":12848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests on the anniversary of the date of grant."}],"balance_after":89527,"source":{"system":"sec-edgar","filing":"0001274225-21-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422521000002/edgardoc.xml","form_type":"4"}},{"id":2955661,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-07T22:14:38.000Z","date":"2020-12-04","kind":"grant","acquired":true,"shares":15889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant."}],"balance_after":76679,"source":{"system":"sec-edgar","filing":"0001274225-20-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422520000002/edgardoc.xml","form_type":"4"}},{"id":3350525,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-06T18:15:41.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":11687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant."}],"balance_after":60790,"source":{"system":"sec-edgar","filing":"0001274225-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422519000002/edgardoc.xml","form_type":"4"}},{"id":3481034,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-06-21T20:01:47.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly over 12 months from June 20, 2019 (\"Grant Date\") in substantially equal monthly installments, provided that the option will vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each such date or, if earlier, such annual meeting."}],"balance_after":25000,"derivative":{"exercise_price":15.44,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-19-017862","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274225/000089924319017862/doc4.xml","form_type":"4"}},{"id":3748100,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-30T17:54:28.000Z","date":"2018-11-29","kind":"grant","acquired":true,"shares":9360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant."}],"balance_after":49103,"source":{"system":"sec-edgar","filing":"0001274225-18-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000013/edgardoc.xml","form_type":"4"}},{"id":3839602,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-08-17T21:00:38.000Z","date":"2018-08-15","kind":"sale","acquired":false,"shares":14531,"price":16,"value":232496.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2018."}],"balance_after":29064,"source":{"system":"sec-edgar","filing":"0000905148-18-000728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274225/000090514818000728/form4.xml","form_type":"4"}},{"id":3839601,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-08-17T21:00:38.000Z","date":"2018-08-15","kind":"sale","acquired":false,"shares":23810,"price":16,"value":380960.0,"ownership":{"direct":false,"nature":"Langer Family Holdings, LLLP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of the shares owned by Langer Family Holdings, LLLP."}],"balance_after":47978,"source":{"system":"sec-edgar","filing":"0000905148-18-000728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274225/000090514818000728/form4.xml","form_type":"4"}},{"id":3883883,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2018-06-25T21:00:40.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly over 12 months from June 21, 2018 (\"Grant Date\") in substantially equal monthly installments, provided that the option will vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each such date or, if earlier, such annual meeting."}],"balance_after":25000,"derivative":{"exercise_price":13.08,"expiration_date":"2028-06-21","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-18-018021","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274225/000089924318018021/doc4.xml","form_type":"4"}},{"id":3900705,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-08T21:37:06.000Z","date":"2018-06-08","kind":"exercise","acquired":false,"shares":13664,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":21.29,"exercise_date":"2012-12-02","expiration_date":"2021-12-02","underlying":"Common Stock","underlying_shares":13664},"source":{"system":"sec-edgar","filing":"0001274225-18-000011","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000011/edgardoc.xml","form_type":"4"}},{"id":3900704,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-08T21:37:06.000Z","date":"2018-06-07","kind":"exercise","acquired":false,"shares":3096,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13664,"derivative":{"exercise_price":21.29,"exercise_date":"2012-12-02","expiration_date":"2021-12-02","underlying":"Common Stock","underlying_shares":3096},"source":{"system":"sec-edgar","filing":"0001274225-18-000011","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000011/edgardoc.xml","form_type":"4"}},{"id":3900703,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-08T21:37:06.000Z","date":"2018-06-06","kind":"exercise","acquired":false,"shares":3609,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16760,"derivative":{"exercise_price":21.29,"exercise_date":"2012-12-02","expiration_date":"2021-12-02","underlying":"Common Stock","underlying_shares":3609},"source":{"system":"sec-edgar","filing":"0001274225-18-000011","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000011/edgardoc.xml","form_type":"4"}},{"id":3900702,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T21:37:06.000Z","date":"2018-06-08","kind":"sale","acquired":false,"shares":13664,"price":39.35,"value":537678.4,"ownership":{"direct":true},"balance_after":39743,"source":{"system":"sec-edgar","filing":"0001274225-18-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000011/edgardoc.xml","form_type":"4"}},{"id":3900701,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T21:37:06.000Z","date":"2018-06-08","kind":"exercise","acquired":true,"shares":13664,"price":21.29,"value":290906.56,"ownership":{"direct":true},"balance_after":53407,"source":{"system":"sec-edgar","filing":"0001274225-18-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000011/edgardoc.xml","form_type":"4"}},{"id":3900700,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T21:37:06.000Z","date":"2018-06-07","kind":"sale","acquired":false,"shares":3096,"price":39.35,"value":121827.6,"ownership":{"direct":true},"balance_after":39743,"source":{"system":"sec-edgar","filing":"0001274225-18-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000011/edgardoc.xml","form_type":"4"}},{"id":3900699,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T21:37:06.000Z","date":"2018-06-07","kind":"exercise","acquired":true,"shares":3096,"price":21.29,"value":65913.84,"ownership":{"direct":true},"balance_after":42839,"source":{"system":"sec-edgar","filing":"0001274225-18-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000011/edgardoc.xml","form_type":"4"}},{"id":3900698,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T21:37:06.000Z","date":"2018-06-06","kind":"sale","acquired":false,"shares":3609,"price":39.3705,"value":142088.1345,"ownership":{"direct":true},"balance_after":39743,"source":{"system":"sec-edgar","filing":"0001274225-18-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000011/edgardoc.xml","form_type":"4"}},{"id":3900697,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T21:37:06.000Z","date":"2018-06-06","kind":"exercise","acquired":true,"shares":3609,"price":21.29,"value":76835.61,"ownership":{"direct":true},"balance_after":43352,"source":{"system":"sec-edgar","filing":"0001274225-18-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000011/edgardoc.xml","form_type":"4"}},{"id":3906657,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-05T21:45:13.000Z","date":"2018-06-01","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":24.4,"exercise_date":"2010-11-05","expiration_date":"2019-11-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001274225-18-000009","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000009/edgardoc.xml","form_type":"4"}},{"id":3906656,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-05T21:45:13.000Z","date":"2018-06-04","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"derivative":{"exercise_price":24.39,"exercise_date":"2009-07-01","expiration_date":"2018-11-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001274225-18-000009","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000009/edgardoc.xml","form_type":"4"}},{"id":3906655,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-05T21:45:13.000Z","date":"2018-06-05","kind":"exercise","acquired":false,"shares":1227,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20369,"derivative":{"exercise_price":21.29,"exercise_date":"2012-12-02","expiration_date":"2021-12-02","underlying":"Common Stock","underlying_shares":1227},"source":{"system":"sec-edgar","filing":"0001274225-18-000009","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000009/edgardoc.xml","form_type":"4"}},{"id":3906654,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-05T21:45:13.000Z","date":"2018-06-04","kind":"exercise","acquired":false,"shares":8404,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21596,"derivative":{"exercise_price":21.29,"exercise_date":"2012-12-02","expiration_date":"2021-12-02","underlying":"Common Stock","underlying_shares":8404},"source":{"system":"sec-edgar","filing":"0001274225-18-000009","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000009/edgardoc.xml","form_type":"4"}},{"id":3906653,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:45:13.000Z","date":"2018-06-05","kind":"sale","acquired":false,"shares":1227,"price":39.9,"value":48957.3,"ownership":{"direct":true},"balance_after":39743,"source":{"system":"sec-edgar","filing":"0001274225-18-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000009/edgardoc.xml","form_type":"4"}},{"id":3906652,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:45:13.000Z","date":"2018-06-05","kind":"exercise","acquired":true,"shares":1227,"price":21.29,"value":26122.83,"ownership":{"direct":true},"balance_after":40970,"source":{"system":"sec-edgar","filing":"0001274225-18-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000009/edgardoc.xml","form_type":"4"}},{"id":3906651,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:45:13.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":8404,"price":39.9,"value":335319.6,"ownership":{"direct":true},"balance_after":39743,"source":{"system":"sec-edgar","filing":"0001274225-18-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000009/edgardoc.xml","form_type":"4"}},{"id":3906650,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:45:13.000Z","date":"2018-06-04","kind":"exercise","acquired":true,"shares":8404,"price":21.29,"value":178921.16,"ownership":{"direct":true},"balance_after":48147,"source":{"system":"sec-edgar","filing":"0001274225-18-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000009/edgardoc.xml","form_type":"4"}},{"id":3906649,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:45:13.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":10000,"price":39.9,"value":399000.0,"ownership":{"direct":true},"balance_after":39743,"source":{"system":"sec-edgar","filing":"0001274225-18-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000009/edgardoc.xml","form_type":"4"}},{"id":3906648,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:45:13.000Z","date":"2018-06-04","kind":"exercise","acquired":true,"shares":10000,"price":24.39,"value":243900.0,"ownership":{"direct":true},"balance_after":49743,"source":{"system":"sec-edgar","filing":"0001274225-18-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000009/edgardoc.xml","form_type":"4"}},{"id":3906647,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:45:13.000Z","date":"2018-06-01","kind":"sale","acquired":false,"shares":30000,"price":38.9,"value":1167000.0,"ownership":{"direct":true},"balance_after":39743,"source":{"system":"sec-edgar","filing":"0001274225-18-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000009/edgardoc.xml","form_type":"4"}},{"id":3906646,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:45:13.000Z","date":"2018-06-01","kind":"exercise","acquired":true,"shares":30000,"price":24.4,"value":732000.0,"ownership":{"direct":true},"balance_after":69743,"source":{"system":"sec-edgar","filing":"0001274225-18-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000009/edgardoc.xml","form_type":"4"}},{"id":3911533,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-01T20:37:30.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":10000,"derivative":{"exercise_price":24.39,"exercise_date":"2018-05-30","expiration_date":"2018-11-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001274225-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000007/edgardoc.xml","form_type":"4"}},{"id":3911532,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-01T20:37:30.000Z","date":"2018-05-30","kind":"sale","acquired":false,"shares":10000,"price":37.9245,"value":379245.0,"ownership":{"direct":true},"balance_after":39743,"source":{"system":"sec-edgar","filing":"0001274225-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000007/edgardoc.xml","form_type":"4"}},{"id":3911531,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-01T20:37:30.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":10000,"price":24.39,"value":243900.0,"ownership":{"direct":true},"balance_after":49743,"source":{"system":"sec-edgar","filing":"0001274225-18-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000007/edgardoc.xml","form_type":"4"}},{"id":3920939,"issuer":{"id":161208,"kind":"organization","name":"PERNIX THERAPEUTICS HOLDINGS, INC.","symbol":"PTX"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-23T17:26:19.000Z","date":"2018-05-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments of 6,250 shares over a four-year period, with the first installment vesting on May 22, 2019, which is the one-year anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":2.63,"expiration_date":"2018-05-21","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001136261-18-000141","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024126/000113626118000141/primary_doc.xml","form_type":"4"}},{"id":3924777,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-05-21T23:54:46.000Z","date":"2018-05-21","kind":"exercise","acquired":false,"shares":10000,"price":35.9,"value":359000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":20000,"derivative":{"exercise_price":24.39,"exercise_date":"2018-05-21","expiration_date":"2018-11-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001274225-18-000005","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000005/edgardoc.xml","form_type":"4"}},{"id":3924776,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-21T23:54:46.000Z","date":"2018-05-21","kind":"sale","acquired":false,"shares":10000,"price":35.9,"value":359000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":39743,"source":{"system":"sec-edgar","filing":"0001274225-18-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000005/edgardoc.xml","form_type":"4"}},{"id":3924775,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-21T23:54:46.000Z","date":"2018-05-21","kind":"exercise","acquired":true,"shares":10000,"price":24.39,"value":243900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":49743,"source":{"system":"sec-edgar","filing":"0001274225-18-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422518000005/edgardoc.xml","form_type":"4"}},{"id":4084677,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-30T21:30:39.000Z","date":"2018-01-26","kind":"exercise","acquired":false,"shares":360,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Langer Family Holdings, LLLP"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12 vests per month, commencing 1 year after the vesting start date of 11/15/2008."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This option was originally reported in the reporting person's Form 3, filed on January 29, 2014, with an expiration date of June 2, 2019.  However, the correct expiration date is February 14, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of the shares owned by Langer Family Holdings, LLLP."}],"balance_after":0,"derivative":{"exercise_price":3.42,"expiration_date":"2018-02-14","underlying":"Common Stock","underlying_shares":360},"source":{"system":"sec-edgar","filing":"0000899243-18-002337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1274225/000089924318002337/doc4.xml","form_type":"4"}},{"id":4084676,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-30T21:30:39.000Z","date":"2018-01-26","kind":"exercise","acquired":true,"shares":360,"price":3.42,"value":1231.2,"ownership":{"direct":false,"nature":"Langer Family Holdings, LLLP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of the shares owned by Langer Family Holdings, LLLP."}],"balance_after":71788,"source":{"system":"sec-edgar","filing":"0000899243-18-002337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274225/000089924318002337/doc4.xml","form_type":"4"}},{"id":4148196,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-01T00:17:51.000Z","date":"2017-11-30","kind":"grant","acquired":true,"shares":7219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant."}],"balance_after":39743,"source":{"system":"sec-edgar","filing":"0001274225-17-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422517000002/edgardoc.xml","form_type":"4"}},{"id":4158782,"issuer":{"id":161208,"kind":"organization","name":"PERNIX THERAPEUTICS HOLDINGS, INC.","symbol":"PTX"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-11-17T15:21:27.000Z","date":"2017-11-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments of 12,500 shares over a four-year period, with the first installment vesting on November 15, 2018, which is the one-year anniversary of the grant date."}],"balance_after":50000,"derivative":{"exercise_price":2.97,"expiration_date":"2027-11-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001136261-17-000286","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024126/000113626117000286/primary_doc.xml","form_type":"4"}},{"id":4253837,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2017-07-20T17:00:40.000Z","date":"2017-07-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly over 12 months from July 11, 2017 in substantially equal monthly installments, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":25000,"derivative":{"exercise_price":3.42,"expiration_date":"2027-07-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-17-018641","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274225/000089924317018641/doc4.xml","form_type":"4"}},{"id":4537708,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-02T00:21:00.000Z","date":"2016-12-01","kind":"grant","acquired":true,"shares":15024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant."}],"balance_after":32524,"source":{"system":"sec-edgar","filing":"0001274225-16-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000127422516000004/edgardoc.xml","form_type":"4"}},{"id":4550050,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-17T17:01:11.000Z","date":"2016-11-16","kind":"sale","acquired":false,"shares":23766,"price":3.52,"value":83656.32,"ownership":{"direct":false,"nature":"Langer Family Holdings, LLLP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of the shares owned by Langer Family Holdings, LLLP."}],"balance_after":71428,"source":{"system":"sec-edgar","filing":"0000899243-16-033800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274225/000089924316033800/doc4.xml","form_type":"4"}},{"id":4564429,"issuer":{"id":161208,"kind":"organization","name":"PERNIX THERAPEUTICS HOLDINGS, INC.","symbol":"PTX"},"owners":[{"id":18719,"kind":"person","name":"LANGER DENNIS","position":1,"cik":"0001274225","reported_name":"LANGER DENNIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-11-08T16:47:03.000Z","date":"2016-11-04","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in annual 1,000 share installments, commencing on the first anniversary of November 4, with the final installment vesting on the fourth anniversary of the vesting start date."}],"balance_after":4000,"derivative":{"exercise_price":3.15,"expiration_date":"2026-11-03","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001136261-16-000656","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1024126/000113626116000656/primary_doc.xml","form_type":"4"}}]}